IHL News: Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement - 28th Oct 2022, 11:00pm

annb0t

Top 20
Incannex Healthcare

MELBOURNE, Australia, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 September 2022. Incannex is undertaking a multitude of U.S. Food and Drug Administration (‘FDA’) programs for cannabinoid pharmaceutical products and psychedelic ...

>>> Read more: Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement
 
Top Bottom